Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

asx hct

  • Home
  •  
  • asx hct



  • Most Read
  • Latest Comments
  • Holista Colltech banks on new partners to turn fortunes as food sales struggle
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Holista Colltech banks on new partners to turn fortunes as food sales struggle
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • Holista Colltech banks on new partners to turn fortunes as food sales struggle
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • Holista Colltech banks on new partners to turn fortunes as food sales struggle
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • Holista Colltech banks on new partners to turn fortunes as food sales struggle
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • Actinogen’s Phase 2a clinical trial for depression treatment fails to meet primary endpoint, shares tank
    Actinogen’s Phase 2a clinical trial for depression treatment fails to meet primary endpoint, shares tank
    • News

  • Holista Colltech banks on new partners to turn fortunes as food sales struggle
    Holista Colltech banks on new partners to turn fortunes as food sales struggle
    • News

  • Zelira Therapeutics nears clinical trial stage for Autism drug following positive FDA feedback
    Zelira Therapeutics nears clinical trial stage for Autism drug following positive FDA feedback
    • News

  • Testing methylone for PTSD treatment: Emyria’s Centre appointed site for clinical trial
    Testing methylone for PTSD treatment: Emyria’s Centre appointed site for clinical trial
    • News

  • Arovella completes development for cell therapy platform, moves to large scale manufacturing
    Arovella completes development for cell therapy platform, moves to large scale manufacturing
    • News

  • Holista Colltech banks on new partners to turn fortunes as food sales struggle
    • News

    Holista Colltech banks on new partners to turn fortunes as food sales struggle

    With mixed quarter results for the June quarter, Holista Colltech (ASX: HCT) – a research-driven biotech company, is trying to stay afloat amidst challenges.  Dedicated to developing and commercialising innovative food products, the Perth based company has seen a decline of 3.7% in overall sales receipts. With a focus on natural ingredients the company has

    Read More
    Public
  • Holista Colltech finally resolves ASIC investigation over pandemic sanitiser claims but with big penalties
    • News

    Holista Colltech finally resolves ASIC investigation over pandemic sanitiser claims but with big penalties

    When COVID was first introduced to the world, everyone wanted a slice of the hand sanitiser market but three years later, misleading claims by producers are being retrospectively called out by regulators, one of which has seen ASIC throw the book at biotech company Holista Colltech (ASX: HCT). After a long-running investigation and litigation which

    Read More
    Public
  • Holista Colltech set to cook up healthy Starbucks croissants
    • News

    Holista Colltech set to cook up healthy Starbucks croissants

    Health foods manufacturer Holista Colltech (ASX: HCT) is set to see its low glycaemic index (GI) food ingredients consumed by thousands of Malaysians having secured their first distribution deal with Country Farms that will see its products supplied to Starbucks Malaysia.  Although only modest in nature to the value of $43,000, Holista is working with

    Read More
    Public
  • COVID pump fizzles as ASX scrutinise Holista Colltech, costly for new investors
    • News

    COVID pump fizzles as ASX scrutinise Holista Colltech, costly for new investors

    Amid the boom of retail investors entering opportunistic penny stocks capitalising on COVID, many are now under the watchful eye of ASX regulators after share price pumps led by business pivots into hygiene product supply such as hand sanitiser.  Just one of many to do so at the start of the pandemic, food production company

    Read More
    Public

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.